Literature DB >> 27389531

The role of B cells and autoantibodies in neuropsychiatric lupus.

Jing Wen1, Ariel D Stock1, Samantha A Chalmers1, Chaim Putterman2.   

Abstract

The central nervous system manifestations of SLE (neuropsychiatric lupus, NPSLE) occur frequently, though are often difficult to diagnose and treat. Symptoms of NPSLE can be quite diverse, including chronic cognitive and emotional manifestations, as well as acute presentations, such as stroke and seizures. Although the pathogenesis of NPSLE has yet to be well characterized, B-cell mediated damage is believed to be an important contributor. B-cells and autoantibodies may traverse the blood brain barrier promoting an inflammatory environment consisting of glia activation, neurodegeneration, and consequent averse behavioral outcomes. This review will evaluate the various suggested roles of B-cells and autoantibodies in NPSLE, as well as therapeutic modalities targeting these pathogenic mediators.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoantibodies; B cells; Neuropsychiatric lupus; SLE

Mesh:

Substances:

Year:  2016        PMID: 27389531      PMCID: PMC4982790          DOI: 10.1016/j.autrev.2016.07.009

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  69 in total

Review 1.  Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.

Authors:  Savino Sciascia; Maria Laura Bertolaccini; Dario Roccatello; Munther A Khamashta; Giovanni Sanna
Journal:  J Neurol       Date:  2014-06-21       Impact factor: 4.849

2.  The incidence and prognosis of central nervous system disease in systemic lupus erythematosus.

Authors:  J T Sibley; W P Olszynski; W E Decoteau; M B Sundaram
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

3.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

4.  Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.

Authors:  Aviva Katzav; Inna Solodeev; Ori Brodsky; Joab Chapman; Chaim G Pick; Miri Blank; Wei Zhang; Morris Reichlin; Yehuda Shoenfeld
Journal:  Arthritis Rheum       Date:  2007-03

Review 5.  Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion.

Authors:  Christopher Barkus; Stephen B McHugh; Rolf Sprengel; Peter H Seeburg; J Nicholas P Rawlins; David M Bannerman
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

6.  Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally.

Authors:  R M Bluthé; B Michaud; K W Kelley; R Dantzer
Journal:  Neuroreport       Date:  1996-06-17       Impact factor: 1.837

7.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

8.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Authors:  Susan Manzi; Jorge Sánchez-Guerrero; Joan T Merrill; Richard Furie; Dafna Gladman; Sandra V Navarra; Ellen M Ginzler; David P D'Cruz; Andrea Doria; Simon Cooper; Z John Zhong; Douglas Hough; William Freimuth; Michelle A Petri
Journal:  Ann Rheum Dis       Date:  2012-05-01       Impact factor: 19.103

9.  Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Authors:  Hilda Fragoso-Loyo; Javier Cabiedes; Alejandro Orozco-Narváez; Luis Dávila-Maldonado; Yemil Atisha-Fregoso; Betty Diamond; Luis Llorente; Jorge Sánchez-Guerrero
Journal:  PLoS One       Date:  2008-10-06       Impact factor: 3.240

10.  Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Authors:  Ariel D Stock; Jing Wen; Jessica Doerner; Leal C Herlitz; Maria Gulinello; Chaim Putterman
Journal:  J Neuroinflammation       Date:  2015-11-06       Impact factor: 8.322

View more
  12 in total

Review 1.  Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.

Authors:  Takanori Ichikawa; Yasuhiro Shimojima; Dai Kishida; Tomoki Kaneko; Yoshiki Sekijima
Journal:  Rheumatol Int       Date:  2020-04-06       Impact factor: 2.631

2.  The SLE-key test serological signature: new insights into the course of lupus.

Authors:  Chaim Putterman; David S Pisetsky; Michelle Petri; Roberto Caricchio; Alan H B Wu; Ignacio Sanz; Jim C Oates; Steve Wallace; Rachel Sorek; Robert Gerwien; Pennina Safer; Keren Jakobi-Brook; Irun R Cohen
Journal:  Rheumatology (Oxford)       Date:  2018-09-01       Impact factor: 7.580

Review 3.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 4.  Leptin: an unappreciated key player in SLE.

Authors:  Qihang Yuan; Haifeng Chen; Xia Li; Jing Wei
Journal:  Clin Rheumatol       Date:  2019-11-09       Impact factor: 2.980

5.  Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations.

Authors:  Rory C Monahan; Michelle D van den Beukel; Nicole V Borggreven; Rolf Fronczek; Tom W J Huizinga; Margreet Kloppenburg; Gerda M Steup-Beekman; Leendert A Trouw
Journal:  RMD Open       Date:  2022-04

Review 6.  Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis.

Authors:  Maryann P Platt; Dritan Agalliu; Tyler Cutforth
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

Review 7.  Psycho-rheumatic Integration in Systemic Lupus Erythematosus: An Insight into Antibodies Causing Neuropsychiatric Changes.

Authors:  Gouthami Nalakonda; Mimsa Islam; Vera E Chukwu; Ahmad Soliman; Rujina Munim; Inas Abukraa
Journal:  Cureus       Date:  2018-08-03

8.  Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Chen Chen; Linyu Geng; Xue Xu; Wei Kong; Yayi Hou; Genhong Yao; Xuebing Feng; Huayong Zhang; Jun Liang
Journal:  Ann Transl Med       Date:  2020-05

9.  Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.

Authors:  Arthur Petitdemange; Julien Blaess; Jean Sibilia; Renaud Felten; Laurent Arnaud
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-16       Impact factor: 5.346

10.  Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.

Authors:  Samantha A Chalmers; Jing Wen; Jessica Doerner; Ariel Stock; Carla M Cuda; Hadijat M Makinde; Harris Perlman; Todd Bosanac; Deborah Webb; Gerald Nabozny; Jay S Fine; Elliott Klein; Meera Ramanujam; Chaim Putterman
Journal:  Arthritis Res Ther       Date:  2018-01-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.